Diabetes Canada / CSEM Professional Conference

Jane

Dr. Yardley completed her PhD in Population Health at the University of Ottawa in 2011. Her doctoral thesis focused on the effects of resistance exercise, on its own or combined with aerobic exercise, in physically active individuals with type 1 diabetes. She is now an Associate Professor at the University of Alberta, and part of the Physical Activity and Diabetes Laboratory at the Alberta Diabetes Institute. Dr. Yardley is still performing research related to type 1 diabetes and exercise. Her current projects focus on resistance exercise and high intensity intermittent intervals, with a particular interest in sex-related differences in blood glucose responses to these modalities. She is a co-author of the 2016 American Diabetes Association Position Statement on Diabetes and Exercise/Physical Activity and a recipient of the Heart and Stroke Foundation of Canada Alberta New Investigator Award.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Speaker's fees: Dexcom Canada
In-kind research support: OneTouch Canada, Abbott Nutrition Canada, Dexcom Canada

Ronald

Dr. Sigal is Professor of Medicine, Kinesiology, Cardiac Sciences and Community Health Sciences at the Cumming School of Medicine, University of Calgary. He is active in clinical medicine, teaching and research.
Dr. Sigal completed residencies in Internal Medicine and Endocrinology at McGill University, and a research fellowship at the McGill Nutrition and Food Sciences Centre. He then completed a Master of Public Health degree and a research fellowship in Epidemiology and Genetics at Harvard University. He has held a Health Senior Scholar award from Alberta Innovates-Health Solutions, and previously a Canadian Institutes of Health Research (CIHR) New Investigator Award. Dr. Sigal’s research focuses on clinical trials related to physical activity, diabetes, kidney disease and cardiovascular disease.
Dr. Sigal has been the lead author of the guidelines on Physical Activity/Exercise for Diabetes Canada (2003, 2008, 2013, 2018) and the American Diabetes Association (2006), and co-Chair of the writing group for the American Diabetes Association Position Statements on Physical Activity/Exercise and Diabetes in 2010 and 2016. He contributed to the chapters on Chronic Diseases and Cardiometabolic Health for the 2018 Physical Activity Guidelines for Americans

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Honoraria for advisory board meeting: Novo Nordisk
Local PI for multicentre trials: Novo Nordisk, Sanofi

Jeff Winterstein

Bio---TBA

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Speaker: ABBOTT, AZ, MERCK, JANSSEN, BI/LILY, SANOFI, BAUSCH, NOVO NORDISK
Grants: NovoNordisk, Astra Fenica

Kate

Kate has been heavily involved in the Do-It-Yourself #wearenotwaiting movement since her daughter Sydney was diagnosed with type 1 diabetes at the age of 8. With a background in information technology and graphic design, Kate has lent her skillset to developing diabetes watch faces for remote monitoring used by patients worldwide. Kate has created an online patient-driven support community for people who are exploring DIY closed-loop solutions and continues to advocate for all people with diabetes to have access to the best tools to manage their diabetes.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose

Denice

Dr. Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto, and holds a cross-appointment in both the Department of Obstetrics and Gynecology and the Department of Health Policy, Management and Evaluation. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and an Adjunct Scientist at the Institute for Clinical and Evaluative Sciences. She is Head of the Diabetes and Endocrine in Pregnancy Program at Mount Sinai Hospital, Chair of the University of Toronto Diabetes in Pregnancy Study Group and Past Chair of the Diabetes in Pregnancy Interest Group for the American Diabetes Association. Her research focus is in the area of diabetes in pregnancy and she was awarded the Canadian Diabetes in Pregnancy Study Group Award for Excellence.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose

Harpreet

Dr. Bajaj is an Endocrinologist and Director of late-phase research at LMC Healthcare. Dr Bajaj started his Endocrinology practice with LMC Brampton in 2009, after completing his clinical fellowship at the Cleveland Clinic (Ohio, USA). Dr Bajaj’s medical education was at Maulana Azad Medical College (New Delhi, India), following which he attained a Masters of Public Health (Epidemiology) at State University of New York in Albany (New York, USA).
Dr. Bajaj is a Research Associate at Mount Sinai Hospital, Toronto, and an adjunct lecturer at McMaster University. He is the principal investigator for the Canadian Diabetes Prevention Program (CDPP), a virtual one-year health and wellness coaching program funded by the Public Health Agency of Canada.
He volunteers with numerous community public health organizations, as well as media programs, with the intent of raising public awareness on diabetes prevention and treatment, with a specific focus on the South Asian origin population in Canada. He is the founder of STOP Diabetes Foundation, a registered charitable organization working to reduce the burden of diabetes in Peel region of Ontario. Dr. Bajaj serves Diabetes Canada on the Executive Board of the Professional Section Executive and as the Vice Chair of clinical practice guidelines.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Honorariums: Banting & Best Diabetes Centre, Brain and Cognition Discovery Found., Diabetes Canada, Eli Lilly, Hu.
Piad to LMC (Institution): Amgen, AstraZeneca, Boehringer Ingelheim, Ceapro, Eli Lilly, Gilead, Janssen, Kowa, Madrigal, Merck

Katie Pundyk

Dr. Senior is Professor of Medicine at the University of Alberta. His research activities and clinical practice are focused on the management and prevention of type 1 diabetes and its complications, and beta cell replacement therapies, including islet transplantation.
He serves as the Chair of the Clinical Practice Guidelines Steering Committee and is a member of the Diabetes Canada Board of Directors.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Honorarium for CGP chair role: Diabetes Canada
Grant funding to my institution for participation as local PI in clinical trials: Novo Nordisk, Viacyte, JDRF

Lorraine

Dr. Lipscombe is the Director of the Division of Endocrinology at Women’s College Hospital and an Associate Professor of Medicine at University of Toronto. She completed her MD from McGill University in 1998, followed by Internal Medicine and Endocrinology training and an MSc in Clinical Epidemiology from University of Toronto. Dr. Lipscombe is a Clinician Scientist with a research focus on the epidemiology, care and prevention of diabetes, and she holds a Diabetes Investigator Award from Diabetes Canada.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Hélène

Dr. Long studied Medicine and did her residence training in Internal Medicine and Endocrinology at the University of Montreal. She works at the CISSS Laval and at the Laval Regional Diabetes Center as a Clinical Endocrinologist and Medical Coordinator. She was also an associated member at the Montreal University Hospital Center from 2006 to 2011. Her particular interests are teaching (patients, trainees and family doctors) and the endocrinology of pregnancy.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Jane

Dr. Yardley completed her PhD in Population Health at the University of Ottawa in 2011. Her doctoral thesis focused on the effects of resistance exercise, on its own or combined with aerobic exercise, in physically active individuals with type 1 diabetes. She is now an Associate Professor at the University of Alberta, and part of the Physical Activity and Diabetes Laboratory at the Alberta Diabetes Institute. Dr. Yardley is still performing research related to type 1 diabetes and exercise. Her current projects focus on resistance exercise and high intensity intermittent intervals, with a particular interest in sex-related differences in blood glucose responses to these modalities. She is a co-author of the 2016 American Diabetes Association Position Statement on Diabetes and Exercise/Physical Activity and a recipient of the Heart and Stroke Foundation of Canada Alberta New Investigator Award.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Speaker's fees: Dexcom Canada
In-kind research support: OneTouch Canada, Abbott Nutrition Canada, Dexcom Canada

Dr. Jon McGavock

Dr. McGavock is an Associate Professor in the Department of Pediatrics and Child Health within the Faculty of Health Sciences at the University of Manitoba. He is currently the co-leader of the DREAM Theme at the Children's Hospital Research Institute of Manitoba. Dr. McGavock held a CIHR New Investigator Salary Award from 2010-2014 and, from 2014-2019, held a CIHR Applied Health Chair in Obesity and Resilience in Indigenous Youth. He is currently one of 12 PIs for the Diabetes Action Canada SPOR Network and the PI for a CIHR Pathways Component 3 team grant focused on prevention of type 2 diabetes among Indigenous youth.

Patrick

Dr. MacDonald completed his PhD in Toronto and followed this with postdoctoral research in Lund, Sweden, and in Oxford. Since 2006, he has run a laboratory at the University of Alberta in Edmonton that has focused on understanding cells in the pancreas that make insulin and other hormones.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Barbara

Dr. Corkey has been the Zoltan Kohn Professor of Medicine and Vice Chair for Research in the Department of Medicine at Boston University. Dr. Corkey has been a leader in the fields of diabetes and obesity research for over 50 years, with about 200 related publications and 40 years of continuous government research support. The Corkey laboratory is engaged in research on obesity and diabetes, with a particular focus on metabolic signal transduction in ß-cells, adipocytes and hepatocytes, intercellular communication via circulating redox and the role of hyperinsulinemia in obesity and diabetes. Projects in metabolic regulation have been ongoing since 1981 using such techniques as single cell imaging, metabolic profiling, ionic fluxes and membrane potential, respiration, redox state, reactive oxygen species generation and diet-induced obesity and diabetes models. She does seminal work on the molecular basis of nutrient signaling that has a major impact on our current understanding of health and disease. Finally, Barbara has received numerous honors, including the NIH MERIT Award, National Honorary Membership in Iota Sigma Pi, the National Honor Society of Women in Chemistry, Women in Science Lecturer at the Boston Museum of Science, the George Bray Founders Award of the Obesity Society, the Charles H. Best Lectureship and Award, University of Toronto, and the Banting Medal for Scientific Achievement from the American Diabetes Association.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Brandy Wickow

Dr. Wicklow is a pediatric endocrinologist, Associate Professor in Pediatrics and Child Health at the University of Manitoba, and Clinician Scientist at the Children's Hospital Research Institute of Manitoba. Her research focuses on the determinants of childhood onset type 2 diabetes and renal complications. She is a principle investigator on 2 cohort studies; the next generation study, which examines the intergenerational risk of type 2 diabetes, and the iCARE cohort study (co-led by Dr Allison Dart), which is examining the psychological and sociological risks for the development of early renal disease in youth with type 2 diabetes. She works closely in partnership with Indigenous communities, families and patients to conduct relevant, patient-oriented research aimed to reduce health disparity and its impacts on First Nations families as it relates to type 2 diabetes.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose

Jenny

Dr. Bruin has been an Assistant Professor at Carleton University in the Department of Biology and Institute of Biochemistry since September 2016. Her lab studies the pathogenesis of diabetes with a focus on islet biology, pancreas development and toxicology. In particular, she is investigating how exposure to persistent environmental pollutants, either during fetal development or adulthood, influences diabetes incidence. Dr. Bruin’s lab is funded by CIHR, NSERC and the Ontario Institute of Regenerative Medicine.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Jeremy

Dr. Gilbert completed his medical degree, Internal Medicine training and Endocrinology residency at the University of Toronto. He is an associate professor at the University of Toronto. He is the Program Director for adult endocrinology and metabolism at the University of Toronto. He has authored a chapter in the 2013 and 2018 Diabetes Canada clinical practice guidelines and was a member of the Steering Committee of the 2018 Diabetes Canada guidelines. He is on the Executive and is a National Editor for the Canadian Journal of Diabetes. He is a passionate teacher and his academic interest is in undergraduate, postgraduate and continuing medical education in diabetes and endocrinology. He has received numerous awards for outstanding teaching.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose

Emily Sims

Dr. Sims is a Physician Scientist specializing in pediatric endocrinology, with a long-term goal of addressing clinically relevant problems in diabetes utilizing molecular discovery. Her research focus revolves around the investigation of molecular mechanisms contributing to β-cell dysfunction and the development of diabetes, as well as the identification and verification of circulating biomarkers of β-cell dysfunction.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Megan

Dr. Levings is a Professor in the Department of Surgery and School of Biomedical Engineering at the University of British Columbia. Her lab studies the biology and clinical application of a special kind of white blood cell, known as a T regulatory cell, that can be used as cellular therapy to stop harmful immune responses. She is internationally recognized in the field of human immunology and currently chairs the Federation of Clinical Immunology Societies Centers' of Excellence and is a member of the NIH-funded Immune Tolerance Network Steering Committee.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Treena

Dr. Treena Wasonti:io Delormier is Kanien’kehá:ka (Mohawk). She is an Associate Professor in the School of Human Nutrition at McGill University, and Associate Director of the Centre for Indigenous Peoples Nutrition and Environment. She is the Scientific Director of the Kahnawake Schools Diabetes Prevention Project (KSDPP), a 24-year community-university partnership and health promotion program in her home community of Kahnawake, near Montreal, Quebec. Dr. Delormier’s research interests include Indigenous research methodologies, qualitative methodologies, Indigenous Peoples’ food systems and the prevention of diabetes and obesity prevention through community mobilization strategies.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Linda

Dr. Diffey is a member of the Peepeekisis Cree Nation in the Treaty 4 region and Indigenous Scholar in Community Health Sciences and Ongomiizwin Indigenous Institute of Health and Healing. She co-led the development and implementation of the Indigenous Health curriculum in undergraduate medical education at the Max Rady College of Medicine and served as a co-editor of the national undergraduate medicine curricular framework for Indigenous health that was developed by the Indigenous Physicians Association of Canada and the Association of Faculties of Medicine of Canada.
Linda is a PhD candidate in the Applied Health Sciences Program at the University of Manitoba. Her dissertation work focuses on the experiences of physician instructors during the implementation of anti-colonial, anti-racist pedagogy in medical education. Other areas of interest include examining systemic colonial oppression within health-related institutions and the application of Indigenous resurgence as a theoretical foundation within Indigenous research methodology.
She has been actively engaged in the mentorship and support of Indigenous students in health research and education for over ten years, and is co-Principal Investigator of the Prairie Indigenous Knowledge Exchange Network (PIKE-Net), part of the CIHR Indigenous Mentorship Network program. In 2018, she was awarded an Indigenous Award of Excellence in the Community Builder category in recognition of her work that seeks to create a safe and supportive work and learning environment for Indigenous students, faculty and staff at the University of Manitoba.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Sonia

Dr. Butalia is a Clinician Scientist in the Departments of Medicine and Community Health Sciences at the University of Calgary. Her research interests are in innovative tools and strategies to improve diabetes and other cardiovascular risk factors in the community. Her program of work importantly engages and is informed by people (i.e. patient partners), health-care providers and decision makers. Her research program is supported by CIHR, Diabetes Canada, the Heart and Stroke Foundation of Canada and Alberta Health Services. Dr. Butalia is also a co-author of several national guidelines in diabetes and hypertension and has contributed to several textbooks. She also teaches at the University of Calgary’s medical school, supervises trainees, and was awarded a Gold Star Resident Teaching Award for her contributions. Finally, she has recently become the Scientific Director of the Diabetes, Obesity and Nutrition Strategic Clinical Network for the province of Alberta.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose
Funded, peer-reviewed grants from not-for profit organizations: Diabetes Canada, Heart and Stroke Foundation of Canada, Alberta Health Services

Katie Pundyk

Katie Pundyk is a Pediatric Endocrinologist at the Winnipeg Children's Hospital, and an Assistant Professor at the University of Manitoba. She completed her Pediatrics residency at the University of Manitoba, and her clinical Pediatric Endocrinology fellowship at the University of Ottawa. She completed an additional year of research training at the University of Manitoba focusing on transition of care in youth with type 2 diabetes, with funding from the Children's Hospital Research Institute of Manitoba and Manitoba Medical Service Foundation.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Gareth

Dr. Lim is an Assistant Professor in the Department of Medicine at the University of Montréal and a Principal Scientist at the University of Montreal Hospital Research Centre (CRCHUM). Currently, he holds the Canada Research Chair in Adipocyte Development. His research is focused on understanding the metabolic functions of the scaffold protein in fat cells and pancreatic beta-cells, and his lab is currently supported by CIHR and NSERC.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Mathieu

During my graduate studies (MSc/PhD, Université Laval, 2002-2007), I developed an expertise in physiology and endocrinology, focusing my attention on adipose tissue metabolism in response to PPARg agonists. In order to improve my capacity to further characterize and understand the molecular mechanisms controlling cellular metabolism, I joined the laboratory of David M. Sabatini (Massachusetts Institute of Technology (MIT)), a world expert in cell signaling primarily known for its work with the kinase mTOR. Over the years that followed (2007-2011), I have been involved in many projects aimed at characterizing the role of mTOR in health, diseases and aging. Over these years, I have published several original articles and reviews on the mTOR pathway. During my postdoctoral training, I learned and mastered several state-of-the-art techniques in molecular biology. I also got the chance to learn how to generate transgenic mouse models. This unique expertise in physiology and molecular biology has greatly helped the establishment of my own laboratory in 2011 (Université Laval). Today, I lead a group of young scientists whose primary objective is to improve the understanding of the molecular mechanisms controlling metabolism in response to environmental challenges. We have a special interest in identifying new biological processes controlling the early development of white adipocytes.

Disclosures

I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose

Jonathan

Dr. Little is an Associate Professor in the School of Health and Exercise Sciences at the University of British Columbia in Kelowna, BC, Canada. He is a Canadian Institutes of Health Research (CIHR) New Investigator and Michael Smith Foundation for Health Research (MSFHR) Scholar whose research focuses on optimizing diet and exercise interventions for the prevention and treatment of type 2 diabetes. He has published over 115 peer-reviewed journal articles in the areas of exercise metabolism, nutrition, type 2 diabetes, obesity and immunology. Ongoing nutrition studies in his lab are exploring how low-carbohydrate diets, nutritional ketosis, and exercise impact glucose control, cardiovascular risk and inflammation.

Dr. Satchin Panda

Dr. Panda is a Professor at the Salk Institute, La Jolla, California. His research focuses on circadian coordination of behavior, physiology and metabolism. His discovery of how a blue light sensor in the eyes affects sleep-wake cycle, depression and alertness is leading a new revolution in managing light to improve health. Recently, Dr. Panda discovered that maintaining a daily feeding-fasting cycle – popularly known as Time-restricted eating (TRE) – can prevent and reverse many chronic diseases and increase lifespan. His lab uses Drosophila, rodents and primates for a mechanistic understanding of the role of circadian rhythm in health. His lab has developed a smartphone app “myCircadianClock,” to facilitate translation of his research to human patients.

Disclosures

I have a relationship with a for-profit and/or a not-for-profit organization to disclose